Authors/Disclosures
|
Ans Van Der Ploeg
(Metabolic Disease and Genetics, Erasmus Medic)
|
The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics . The institution of Ans Van Der Ploeg has received research support from Sanofi Genzyme. |
|
Paula R. Clemens, MD
(Univ of Pittsburgh/ Dept of Neurology)
|
The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA. |
|
|
No disclosure on file |
|
Diana M. Escolar, MD, FAAN
|
No disclosure on file |
|
Yasuo Iwasaki, MD
|
No disclosure on file |
|
Julaine M. Florence
(Washington University)
|
Ms. Florence has nothing to disclose. |
|
Pascal Laforet
(Hopital Pitie Salpetriere)
|
No disclosure on file |